Rhythm Pharmaceuticals Presents New Data from Phase 2 Basket Study Showing Continued ...

Responders with HET obesity achieved mean weight loss of greater than 12 percent at nine months on setmelanotide therapy —. — Additional poster ...

from Google Alert - How to lose weight https://ift.tt/2NFIhRg